www.fasteris.com
From yesterday to tomorrow: past, present and future of sequencing
The NGS revolu-on
Laurent FARINELLI 19 October 2017
ICCMg2 Second Interna<onal Conference on Clinical Metagenomics
Geneva, Switzerland
From yesterday to tomorrow: past, present and future of sequencing - - PowerPoint PPT Presentation
From yesterday to tomorrow: past, present and future of sequencing The NGS revolu-on Laurent FARINELLI 19 October 2017 ICCMg2 Second Interna<onal Conference on Clinical Metagenomics Geneva, Switzerland www.fasteris.com Be at the right place
www.fasteris.com
Laurent FARINELLI 19 October 2017
ICCMg2 Second Interna<onal Conference on Clinical Metagenomics
Geneva, Switzerland
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
2
7 instruments ABI 377 Streptococcus pneumoniae
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
3
Lynx Therapeu-cs’ MegaClone Massively Parallel Signature Sequencing (MPSS) Gene Expression Profiling
Brenner, S. et al., Nature Biotechnology 18:630-634 (2000)
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
4
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
5
13 November 1996:
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
6
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
7
GlaxoWellcome
Serono
GenInEx / Manteia Predic=ve Medicine With your genome on CD you consult our database to predict response to treatment or risk of disease
including Y-shaped adapter (Laurent) and P5, P7 (Magne)
Solexa & Lynx Therapeu-cs ($4 M)
illumina ($600 M)
A A T T
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
8 Everything started in a chalet...
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
9
Library Preparation Kit Solexa Genome Analyzer Solexa Cluster Station
Data analysis
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
10
Plasmid NOT included in the reference sequence => artefact and false SNPs
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
11
ChIP-SEQ
Microsporidia
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
12
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
13
2013: Whole genome 2015: Reimbursed T13, 18, 21
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
14
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
15
www.fasteris.com
25 January 2017 Laurent Farinelli – Université Paris Descartes (c) 2017, Fasteris SA
16
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
17
www.fasteris.com
IMPORTANT NOTICE
This document provides information for an application for Illumina technology that has been demonstrated internally and may be of interest to customers. This information is provided as‐is and is not an Illumina product and is not accompanied by any rights or
required and materials from authorized vendors. Illumina products mentioned herein are for research use only unless marked otherwise. While customer feedback is welcomed, this application is not supported by Illumina Technical Support and Field Application Scientists. Part # 15044223 Rev. B
Page 1
16S Metagenomic Sequencing Library Preparation
Preparing 16S Ribosomal RNA Gene Amplicons for the Illumina MiSeq System
Introduction 2 16S Library Preparation Workflow 5 Amplicon PCR 6 PCR Clean‐Up 8 Index PCR 10 PCR Clean‐Up 2 13 [Optional] Validate Library 15 Library Quantification, Normalization, and Pooling 16 Library Denaturing and MiSeq Sample Loading 17 MiSeq Reporter Metagenomics Workflow 20 Supporting Information 21 Figure 1 16S V3 and V4 Amplicon Workflow User‐defined forward and reverse primers that are complementary upstream and downstream of the region of interest are designed with overhang adapters, and used to amplify templates from genomic
Illumina sequencing adapters. Libraries are normalized and pooled, and sequenced on the MiSeq system using v3 reagents.
Amplicon Primers
are selected from the Klindworth et al. publication (Klindworth A, Pruesse E, Schweer T, Peplles J, Quast C, et al. (2013) Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next‐generation sequencing‐based diversity studies. Nucleic Acids Res 41(1).) as the most promising bacterial primer pair. Illumina adapter
primer sequences, using standard IUPAC nucleotide nomenclature, to follow the protocol targeting this region are: 16S Amplicon PCR Forward Primer = 5' TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG 16S Amplicon PCR Reverse Primer = 5' GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC
with other sets of primer pairs, or non‐16S regions throughout the genome; ie any amplicon). The overhang adapter sequence must be added to the locus‐specific primer for the region to be targeted (Figure 1). The Illumina overhang adapter sequences to be added to locus‐specific sequences are: Forward overhang: 5’ TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG‐[locus‐ specific sequence] Reverse overhang: 5’ GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG‐[locus‐ specific sequence]
Introduction Page 3
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
18
Using primers with long tags (>60 nucleo-des) Advantage:
in one step. Inconvenient:
Expensive and significant impact on amplifica-on efficiency
1st step with primers with medium tag (30 nt) 2nd step with illumina primers Advantage:
Inconvenient:
Libraries with low complexity
All inserts in the same orienta-on with similar sequences => Impact on sequence quality
www.fasteris.com
tag 1 specific primer 1 specific primer 2 tag 2
Step 1: PCR using primers with short tags Step 2: Normalization and pooling Step 3: End-repair, A-tailing and TruSeq adapter ligation
Tags 1 NNAACCGT 2 NNCGATGT 3 NNNGTGAGC 4 NNNTCCGCT 5 NNNNACAGTG 6 NNNNCTTGTA 7 NNGACTCT 8 NNTGACCA 9 NNNATCACG 10 NNNCCGGAG 11 NNNNGGCTAC 12 NNNNTAGCTT 13 NNACTTGA 14 NNCAGATC 15 NNNGGTATA 16 NNNTTTAGG 17 NNNNAGAAGA 18 NNNNGATCAG 19 NNTTGTTC 20 NNATTCGC 21 NNNCGTTAA 22 NNNGAGGAT 23 NNNNTTAGGC 24 NNNNGCCAAT
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
19
www.fasteris.com
≈ 10% chimera
≈ 1% chimera
≈ 0.1% chimera
TagF1 TagF2 TagF3 TagF4 TagF5 TagF6 TagF7 TagF8 TagR1
90.44 99.76 1.61 0.04 0.89 0.02 1.37 0.06 1.79 0.02 1.49 0.03 1.1 0.02 1.32 0.05
TagR2
1.24 0.03 90.51 99.8 1.1 0.02 1.44 0.05 2.08 0.03 1.21 0.03 0.96 0.01 1.45 0.03
TagR3
1.13 0.03 1.62 0.02 90.16 99.82 1.61 0.04 1.82 0.02 1.24 0.04 0.96 0.02 1.46 0.02
TagR4
0.83 0.01 1 0.01 0.83 93.39 99.92 1.42 0.03 0.85 0.01 0.68 0.99 0.01
TagR5
1.03 0.03 1.47 0.02 0.92 0.01 1.42 0.04 91.69 99.83 1.05 0.02 0.83 0.02 1.6 0.03
TagR6
1.47 0.04 1.28 0.02 0.87 0.02 1.32 0.07 1.64 0.04 90.88 99.71 1.2 0.07 1.32 0.04
TagR7
1.72 0.03 1.7 0.02 1.22 0.02 1.59 0.05 2.06 0.03 1.78 0.04 88.01 99.75 1.94 0.06
TagR8
1.16 0.04 1.64 0.03 0.96 0.02 1.54 0.04 2.36 0.02 1.32 0.03 1.19 0.01 89.84 99.82
With 5 cycles PCR MetaFast (no PCR)
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
20
Samples 1 – 8, Fwd Tag Rev Tags Found
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
21
Large number of PCRs can be pooled to prepare a single illumina library
Very low incidence on amplifica-on efficiency
Increases sequence variability
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
22
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
23
Sequencing speed
4 10 300 50 100 150 200 250 300 350 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 Year Bases / sec
7 instruments ABI 377 1 setup ABI 3730xl Solexa 1G
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
24
Sequencing speed
10000 20000 30000 40000 50000 60000 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 Year Bases / sec
7 instruments ABI 377 1 setup ABI 3730xl GA 1G GA II P-E GA IIx Pipeline 1.6 GA II Pipeline 1.4
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
25
Sequencing speed
100000 200000 300000 400000 500000 600000 700000 800000 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 Q2, 2010 Q2, 2011 Year Bases / sec
7 instruments ABI 377 1 setup ABI 3730xl GA 1G GA II P-E GA IIx Pipeline 1.4 and 1.6 HiSEQ-2000 June 2010 HiSEQ-2000 June 2011 HiSEQ-2500 1Tb Mid-2014
bases per second
NovaSeq 2017
bases per second
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
26
=> Importance of analysis
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
27
www.fasteris.com
19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
28
that we’ll hear about during ICCMg2 !
www.fasteris.com
Sales & Marketing
Axel STRITTMATTER François ALLER Svetlana SKARUPELOVA Aneliya ETROPLOSKA
NGS Production
Cécile DELUEN SAGNE Christelle BARRAS Elisabeth DIETERLE ZARE Cristel BUSCA Franz PELEGRIN Sonia PERREIRA Vianney FRIGARD Fanny JOLY
Sanger Sequencing
Anne SCHOENDORF Chloé HOT Christophe BUSER
Bioinformatics & IT
Loïc BAERLOCHER Gérald BLANC Manuele CASTELNUOVO Nicolas GONZALEZ Patricia OTTEN
Administration
Laurent FARINELLI Isabelle LOROLE
Quality
Gilles MATTON Benoît WINIGER
Development
Marta COTADO Pauline CHARRUAU
Research
Nadine VINCENT Magne OSTERAS
Diagnostics / FAMH
Frédéric GUERRY (AUR) Marco BELFIORE (MCL) Fabien MURISIER (FER) 19 October 2017 Second Interna-onal Conference on Clinical Metagenomics (c) 2017, Fasteris SA
29